




Searching News Database: R Series
HSMN NewsFeed - 19 Mar 2025
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
HSMN NewsFeed - 28 Feb 2023
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 1 Dec 2021
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 16 Jun 2021
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
HSMN NewsFeed - 20 Aug 2020
LensGen(R) Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors
LensGen(R) Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors
HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
HSMN NewsFeed - 16 Jul 2018
Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases
Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases
HSMN NewsFeed - 9 May 2018
Adventus Ventures announces initial financing for several of its medical device portfolio companies
Adventus Ventures announces initial financing for several of its medical device portfolio companies
HSMN NewsFeed - 24 Jan 2018
Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 6 Jan 2016
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
HSMN NewsFeed - 15 Sep 2015
Harpoon Medical Enrolls Ten Patients in Early Feasibility Study with 100% Procedural Success
Harpoon Medical Enrolls Ten Patients in Early Feasibility Study with 100% Procedural Success
HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
HSMN NewsFeed - 18 Jun 2015
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
HSMN NewsFeed - 8 Apr 2014
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device
Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device
HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
HSMN NewsFeed - 13 Jun 2013
PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
HSMN NewsFeed - 3 Dec 2012
Toshiba MR System Expands Clinical Capabilities, Improves Patient Comfort at Fairview Hospital
Toshiba MR System Expands Clinical Capabilities, Improves Patient Comfort at Fairview Hospital
HSMN NewsFeed - 12 Apr 2012
New BIOTRONIK ICD and CRT-D Series Gives Patients First-Ever Access to MR Scans
New BIOTRONIK ICD and CRT-D Series Gives Patients First-Ever Access to MR Scans
HSMN NewsFeed - 12 Mar 2012
HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing
HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing
HSMN NewsFeed - 7 Feb 2012
Boston Scientific WallFlex(R) Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries
Boston Scientific WallFlex(R) Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries
HSMN NewsFeed - 30 Jan 2012
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
HSMN NewsFeed - 25 Apr 2011
Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System
Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System
HSMN NewsFeed - 29 Oct 2010
Roche Introduces Immunoassay Module for cobas(R) 8000 Modular Analyzer Series In U.S.
Roche Introduces Immunoassay Module for cobas(R) 8000 Modular Analyzer Series In U.S.
HSMN NewsFeed - 29 Jul 2010
ZOLL AED Plus and AED Pro Approved by Japan Medical Device Safety Division and Office of Medical Devices
ZOLL AED Plus and AED Pro Approved by Japan Medical Device Safety Division and Office of Medical Devices
HSMN NewsFeed - 19 May 2009
Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
HSMN NewsFeed - 22 Jan 2009
Zoll Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators
Zoll Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators
HSMN NewsFeed - 14 Jul 2008
Tornier Reaches the 100,000 Implant Milestone with the Aequalis Shoulder System
Tornier Reaches the 100,000 Implant Milestone with the Aequalis Shoulder System
HSMN NewsFeed - 20 Nov 2007
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
HSMN NewsFeed - 24 Oct 2007
HistoRx Raises $6.0 Million in Series B Funding to Advance Diagnostic Product Development
HistoRx Raises $6.0 Million in Series B Funding to Advance Diagnostic Product Development
HSMN NewsFeed - 27 Sep 2007
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
HSMN NewsFeed - 5 Sep 2007
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
HSMN NewsFeed - 29 Jan 2007
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
HSMN NewsFeed - 28 Dec 2006
ZOLL Receives Marketing Clearance for R Series ''Code-Ready'' Defibrillator in Canada
ZOLL Receives Marketing Clearance for R Series ''Code-Ready'' Defibrillator in Canada
HSMN NewsFeed - 20 Dec 2006
RedPath Integrated Pathology, Inc. Concludes Series A Round With $6.5 Million in Venture Capital
RedPath Integrated Pathology, Inc. Concludes Series A Round With $6.5 Million in Venture Capital
HSMN NewsFeed - 10 Nov 2006
ZOLL Launches First and Only ''Code-Ready'' Defibrillator for Hospitals: R Series
ZOLL Launches First and Only ''Code-Ready'' Defibrillator for Hospitals: R Series
Additional items found! 37

Members Archive contains
37 additional stories matching:
R Series
(Password required)
R Series
(Password required)